Related Experiment Video
Updated: Jun 21, 2026

Two-photon Imaging of Microglial Processes' Attraction Toward ATP or Serotonin in Acute Brain Slices
Published on: January 31, 2019
Modulation of the ATP-lnduced release and processing of IL-1beta in microglial cells
Takato Takenouchi1, Shuei Sugama, Yoshifumi Iwamaru
1Transgenic Animal Research Center, National Institute of Agrobiological Sciences, Ohwashi, Tsukuba, Ibaraki, Japan
Abstract:
IL-1beta is one of the most potent proinflammatory cytokines. It is primarily released from activated microglia in the brain, and is also implicated in the induction and progression of pathogenesis in various neurodegenerative disorders. Therefore, to clarify the regulatory or modulatory mechanisms for maturation and release of IL-1beta from microglia may provide therapeutic clues for neuroinflammatory/neurodegenerative diseases. IL-1beta lacks a secretory signal sequence, and thus is not transported through the classical cndoplasmic reticulum/ Golgi-mediated pathway. Although the mechanisms for the release of mature IL-1beta still remain controversial, emerging evidence suggests the pivotal roles of the P2X7 receptor (P2X7R), one of the ionotropic P2X receptors for extracellular ATP, in the release of this cytokine. Here, we review the current studies regarding the modulatory mechanisms of P2X7R-dependent maturation and the release of IL-1beta from microglial cells, focusing on the novel roles of lysophospholipids in this process.
Insights
Interleukin-1 beta (IL-1beta) release from microglia involves the P2X7 receptor (P2X7R). Lysophospholipids modulate this process, offering potential therapeutic targets for neuroinflammation and neurodegenerative diseases.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Interleukin-1 beta (IL-1beta) is a potent pro-inflammatory cytokine primarily released by activated microglia in the brain.
- IL-1beta plays a critical role in the pathogenesis of neurodegenerative disorders.
- Understanding IL-1beta release mechanisms is crucial for developing therapeutic strategies for neuroinflammatory diseases.
Purpose of the Study:
- To review the regulatory mechanisms of IL-1beta maturation and release from microglial cells.
- To elucidate the role of the P2X7 receptor (P2X7R) in IL-1beta release.
- To highlight the involvement of lysophospholipids in P2X7R-dependent IL-1beta release.
Main Methods:
- Literature review of studies on microglial IL-1beta release.
- Focus on P2X7R signaling pathways.
- Analysis of lysophospholipid modulation of IL-1beta secretion.
Main Results:
- IL-1beta is released from microglia independently of the classical endoplasmic reticulum/Golgi pathway.
- The P2X7 receptor (P2X7R) is a key mediator in the release of mature IL-1beta.
- Lysophospholipids emerge as significant modulators of P2X7R-dependent IL-1beta release.
Conclusions:
- P2X7R signaling is central to microglial IL-1beta release.
- Lysophospholipids represent novel targets for modulating neuroinflammation via P2X7R.
- Targeting P2X7R and lysophospholipid pathways may offer therapeutic avenues for neurodegenerative diseases.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
IP3/DAG Signaling Pathway
